Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.53 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.53 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.53 |
| ▸ | ESR1 | P03372 | 4/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.47 |
| ▸ | NQO2 | P16083 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | TYR | P14679 | 2/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA3 | P07451 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL83882 | 1.00 | AKR1C3 (0.69) | AKR1C3ALDH1A1KDM4ECISD1SLC16A3 | |
| SCHEMBL5606699 | 0.98 | AKR1C3 (0.67) | AKR1C3ALDH1A1KDM4ECISD1SLC16A3 | |
| SCHEMBL5607117 | 0.98 | AKR1C3 (0.67) | AKR1C3ALDH1A1KDM4ECISD1SLC16A3 | |
| SCHEMBL5607416 | 0.98 | AKR1C3 (0.67) | AKR1C3ALDH1A1KDM4ECISD1SLC16A3 | |
| SCHEMBL5606972 | 0.98 | AKR1C3 (0.67) | AKR1C3ALDH1A1KDM4ECISD1SLC16A3 | |
| SCHEMBL5607656 | 0.98 | AKR1C3 (0.67) | AKR1C3ALDH1A1KDM4ECISD1SLC16A3 | |
| SCHEMBL5607459 | 0.98 | AKR1C3 (0.67) | AKR1C3ALDH1A1KDM4ECISD1SLC16A3 | |
| SCHEMBL5607681 | 0.98 | AKR1C3 (0.67) | AKR1C3ALDH1A1KDM4ECISD1SLC16A3 | |
| SCHEMBL5607625 | 0.98 | AKR1C3 (0.67) | AKR1C3ALDH1A1KDM4ECISD1SLC16A3 | |
| Ammonia Solution, Strong SCHEMBL5607443 | 0.98 | AKR1C3 (0.67) | AKR1C3ALDH1A1KDM4ECISD1SLC16A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 531 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020129611-A1 | POLYMER HAVING HYDROPHILIC PROTECTING GROUP FOR RESISTS | 丸善石油化学株式会社 | 2020-06-25 | — | — | WO | claimed |
| EP-0980203-B1 | ANTIMICROBIAL PREVENTION AND TREATMENT OF HUMAN IMMUNEDEFICIENCY VIRUS AND OTHER INFECTIOUS DISEASES | SQUIRES MERYL (US) | 2007-04-04 | — | — | EP | claimed |
| EP-1038668-B1 | Photosensitive composition and planographic printing plate precursor using same | FUJI PHOTO FILM CO LTD (JP) | 2005-05-25 | — | — | EP | claimed |
| EP-0914964-B1 | Positive type photosensitive composition for infrared lasers | FUJI PHOTO FILM CO LTD (JP) | 2004-12-29 | — | — | EP | claimed |
| EP-0980203-A4 | ANTIMICROBIAL PREVENTION AND TREATMENT OF HUMAN IMMUNEDEFICIENCY VIRUS AND OTHER INFECTIOUS DISEASES | SQUIRES MERYL (US) | 2004-05-06 | — | — | EP | claimed |
| US-20030143490-A1 | Resist pattern thickness reducing material, resist pattern and process for forming thereof, and semiconductor device and process for manufacturing thereof | FUJITSU LIMITED (JP) | 2003-07-31 | — | — | US | claimed |
| EP-0909657-B1 | A positive type photosensitive image-forming material for an infrared laser | FUJI PHOTO FILM CO LTD (JP) | 2003-06-18 | — | — | EP | claimed |
| US-20030104082-A1 | Antimicrobial prevention and treatment of human immunedeficience virus and other infectious diseases | MCGINLEY PARTNERS, LLC (US) | 2003-06-05 | — | — | US | claimed |
| EP-0980203-A1 | ANTIMICROBIAL PREVENTION AND TREATMENT OF HUMAN IMMUNEDEFICIENCY VIRUS AND OTHER INFECTIOUS DISEASES | Squires, Meryl (US) | 2000-02-23 | — | — | EP | claimed |
| WO-1998042188-A1 | ANTIMICROBIAL PREVENTION AND TREATMENT OF HUMAN IMMUNEDEFICIENCY VIRUS AND OTHER INFECTIOUS DISEASES | SQUIRES MERYL (US) | 1998-10-01 | — | — | WO | claimed |
| US-4748161-A | Triterpenyl esters of organic acids and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1988-05-31 | — | — | US | claimed |
| EP-0166542-A2 | Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1986-01-02 | — | — | EP | claimed |
| EP-3950753-B1 | PHOTOSENSITIVE RESIN COMPOSITION, CURED FILM, INDUCTOR AND ANTENNA | FUJIFILM CORP (JP) | 2026-03-25 | — | — | EP | disclosed |
| US-12391783-B2 | Polymer compound, and resin composition containing said compound | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2025-08-19 | — | — | US | disclosed |
| CN-120019085-A | Method for producing polymer | 丸善石油化学株式会社 | 2025-05-16 | — | — | CN | disclosed |
| WO-2025100122-A1 | ELECTRODE PERIPHERAL EMBEDDING MATERIAL, PRE-BAKED FILM OF ELECTRODE PERIPHERAL EMBEDDING MATERIAL, METHOD FOR PRODUCING PRE-BAKED FILM OF ELECTRODE PERIPHERAL EMBEDDING MATERIAL, AND MICRO-LED DISPLAY ELEMENT | 日産化学株式会社 | 2025-05-15 | — | — | WO | disclosed |
| US-4210577-A | Stabilizers for synthetic polymers comprising 2,2,6,6-tetramethyl-4-piperidyl carboxylic acid ester, phosphonic acid ester and phenol | ARGUS CHEMICAL CORPORATION (US) | 1980-07-01 | — | — | US | disclosed |
| US-4209431-A | OXIDATION AND HEAT RESISTANCE | WITCO CHEMICAL CORPORATION (US) | 1980-06-24 | — | — | US | disclosed |
| US-4080364-A | Stabilization of polyolefins against degradative deterioration as a result of exposure to light and air at elevated temperatures | ARGUS CHEMICAL CORPORATION (US) | 1978-03-21 | — | — | US | disclosed |
| US-3997551-A | OXIDATION RESISTANCE, STABILIZE POLYMERS | ARGUS CHEMICAL CORPORATION (US) | 1976-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030104082-A1 | Antimicrobial prevention and treatment of human immunedeficience virus and other infectious diseases | CD14, CD59, SLC19A1 | AKR1C3 1099/4885ALDH1A1 1759/4885KDM4E 3962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.